TREAT: Ticagrelor Safe in STEMI Patients After Fibrinolysis TREAT: Ticagrelor Safe in STEMI Patients After Fibrinolysis

Randomized but open-label data show ticagrelor was noninferior to clopidogrel in terms of major bleeding at 30 days for patients with ST-segment elevation MI.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news